P53 suppresses expression of the 14-3-3gamma oncogene

BMC Cancer

Vijayababu M Radhakrishnan³  Charles W Putnam⁴  Wenqing Qi²  Jesse D Martinez¹ 

[1] Arizona Cancer Center, Department of Cellular & Molecular Medicine, University of Arizona, Tucson, Arizona 85724, USA

[2] Department of Medicine, 1515 N. Campbell Ave., Tucson, Arizona 85724, USA

[3] Department of Pediatrics, Steele Research Center, 1501 N Campbell Ave, Tucson, Arizona 85724, USA

[4] Department of Surgery, 1501 N Campbell ave, Tucson, Arizona 85724, USA

关键词: Transcription Regulation;    Gene Copy;    p53 mutations;    14-3-3;    Lung cancer;   

Others  :  1080757
DOI  :  10.1186/1471-2407-11-378

 received in 2011-03-14, accepted in 2011-08-25,  发布年份 2011

【 摘 要 】

Background

14-3-3 proteins are a family of highly conserved proteins that are involved in a wide range of cellular processes. Recent evidence indicates that some of these proteins have oncogenic activity and that they may promote tumorigenesis. We previously showed that one of the 14-3-3 family members, 14-3-3gamma, is over expressed in human lung cancers and that it can induce transformation of rodent cells in vitro.

Methods

qRTPCR and Western blot analysis were performed to examine 14-3-3gamma expression in non-small cell lung cancers (NSCLC). Gene copy number was analyzed by qPCR. P53 mutations were detected by direct sequencing and also by western blot. CHIP and yeast one hybrid assays were used to detect p53 binding to 14-3-3gamma promoter.

Results

Quantitative rtPCR results showed that the expression level of 14-3-3gamma was elevated in the majority of NSCLC that we examined which was also consistent with protein expression. Further analysis of the expression pattern of 14-3-3gamma in lung tumors showed a correlation with p53 mutations suggesting that p53 might suppress 14-3-3 gamma expression. Analysis of the gamma promoter sequence revealed the presence of a p53 consensus binding motif and in vitro assays demonstrated that wild-type p53 bound to this motif when activated by ionizing radiation. Deletion of the p53 binding motif eliminated p53's ability to suppress 14-3-3gamma expression.

Conclusion

Increased expression of 14-3-3gamma in lung cancer coincides with loss of functional p53. Hence, we propose that 14-3-3gamma's oncogenic activities cooperate with loss of p53 to promote lung tumorigenesis.

【 授权许可】

   
2011 Radhakrishnan et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Muslin AJ, Tanner JW, Allen PM, Shaw AS: Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 1996, 84(6):889-97.
• [2]Fu H, Subramanian RR, Masters SC: 14-3-3 proteins: structure, function, and regulation. Annual review of pharmacology and toxicology 2000, 40:617-47.
• [3]Hermeking H, Lengauer C, Polyak K, et al.: 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Molecular cell 1997, 1(1):3-11.
• [4]Porter GW, Khuri FR, Fu H: Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Seminars in cancer biology 2006, 16(3):193-202.
• [5]Thorson JA, Yu LW, Hsu AL, et al.: 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Molecular and cellular biology 1998, 18(9):5229-38.
• [6]Ichimura T, Isobe T, Okuyama T, Yamauchi T, Fujisawa H: Brain 14-3-3 protein is an activator protein that activates tryptophan 5-monooxygenase and tyrosine 3-monooxygenase in the presence of Ca2+, calmodulin-dependent protein kinase II. FEBS letters 1987, 219(1):79-82.
• [7]Berg D, Holzmann C, Riess O: 14-3-3 proteins in the nervous system. Nature reviews 2003, 4(9):752-62.
• [8]Qi W, Liu X, Qiao D, Martinez JD: Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. International journal of cancer 2005, 113(3):359-63.
• [9]Cheng L, Pan CX, Zhang JT, et al.: Loss of 14-3-3sigma in prostate cancer and its precursors. Clin Cancer Res 2004, 10(9):3064-8.
• [10]Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S: Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 2001, 20(26):3348-53.
• [11]Matta A, Bahadur S, Duggal R, Gupta SD, Ralhan R: Over-expression of 14-3-3zeta is an early event in oral cancer. BMC cancer 2007, 7:169. BioMed Central Full Text
• [12]Akahira J, Sugihashi Y, Suzuki T, et al.: Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Clin Cancer Res 2004, 10(8):2687-93.
• [13]Guweidhi A, Kleeff J, Giese N, et al.: Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Carcinogenesis 2004, 25(9):1575-85.
• [14]Okada T, Masuda N, Fukai Y, et al.: Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas. Anticancer research 2006, 26(4B):3105-10.
• [15]Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B: 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999, 401(6753):616-20.
• [16]Urano T, Saito T, Tsukui T, et al.: Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 2002, 417(6891):871-5.
• [17]Dellambra E, Golisano O, Bondanza S, et al.: Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. The Journal of cell biology 2000, 149(5):1117-30.
• [18]Jin YH, Kim YJ, Kim DW, et al.: Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53. Biochemical and biophysical research communications 2008, 368(3):690-5.
• [19]Qi W, Liu X, Chen W, Li Q, Martinez JD: Overexpression of 14-3-3gamma causes polyploidization in H322 lung cancer cells. Molecular carcinogenesis 2007, 46(10):847-56.
• [20]Carney DN: Oncogenes and genetic abnormalities in lung cancer. Chest 1989, 96(1 Suppl):25S-7S.
• [21]Massion PP, Kuo WL, Stokoe D, et al.: Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer research 2002, 62(13):3636-40.
• [22]Kuo MH, Allis CD: In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment. Methods (San Diego, Calif 1999, 19(3):425-33.
• [23]Radhakrishnan VM, Martinez JD: 14-3-3gamma induces oncogenic transformation by stimulating MAP kinase and PI3K signaling. PloS one 5(7):e11433.
• [24]Fu L, Benchimol S: Participation of the human p53 3'UTR in translational repression and activation following gamma-irradiation. The EMBO journal 1997, 16(13):4117-25.
• [25]Riley T, Sontag E, Chen P, Levine A: Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008, 9(5):402-12.